In a scenario of increasing alarm about food waste due to rapid urbanization, population growth and lifestyle changes, this study aims to explore the valorization of waste from the retail sector as potential substrates for the biotechnological production of biosurfactants. With a perspective of increasingly contributing to the realization of the circular bioeconomy, a vegetable juice, derived from unsold fruits and vegetables, as a carbon source was used to produce lipopeptides such as surfactin and fengycin. The results from the shake flask cultivations revealed that different concentrations of vegetable juice could effectively serve as carbon sources and that the fed-batch bioreactor cultivation strategy allowed the yields of lipopeptides to be significantly increased. In particular, the product/substrate yield of 0.09 g/g for surfactin and 0.85 mg/g for fengycin was obtained with maximum concentrations of 2.77 g/L and 27.53 mg/L after 16 h, respectively. To conclude, this study provides the successful fed-batch cultivation of B. subtilis using waste product as the carbon source to produce secondary metabolites. Therefore, the consumption of agricultural product wastes might be a promising source for producing valuable metabolites which have promising application potential to be used in several fields of biological controls of fungal diseases.

This study assesses the efficacy of three white-rot fungi—Bjerkandera adusta, Phanerochaete chrysosporium, and Trametes versicolor—in degrading synthetic dyes and lignin in pulp and paper mill effluents, which annually contribute around 40,000 million cubic meters of dyed waste. Exploiting the structural resemblance of dyes to lignin, the fungi utilize ligninolytic enzymes—lignin peroxidase, manganese peroxidase, and laccase—to break down the pollutants. Initial mycoremediation trials in synthetic dye solutions with Direct black 80, Direct yellow 11, Basic brown 1, Orange II, and Red 8 BLP achieved decolorization rates of 70–80% within 7 days, except for Red 8 BLP. Both soluble and insoluble lignin fractions were significantly reduced, with an overall removal rate of 80–90%. Contrary to prior beliefs about the recalcitrance of azo dyes, B. adusta demonstrated substantial biodegradation capabilities, even on non-lignocellulosic substrates, such as dairy waste. The decolorization efficacy varied with dye structure, suggesting that efficiency should not be judged solely on color reduction. Remarkably, B. adusta also effectively decolorized and removed lignin from actual mill effluents without pH alteration, indicating a viable low-cost bioremediation strategy. This invites further investigation into optimizing B. adusta for industrial wastewater biodecolorization, especially in the field of PAHs (Polycyclic Aromatic Hydrocarbons) and EDCs (Endocrine Disrupting Chemicals).

Supply chain waste gives rise to significant challenges in terms of disposal, making upcycling a promising and sustainable alternative for the recovery of bioactive compounds from by-products. Lignocellulosic by-products like STF231, which are derived from the medicinal plant extract industry, offer valuable compounds such as polyphenols and iridoids that can be recovered through upcycling. In an unprecedented study, we explored and compared conventional hydroethanolic extraction, ultrasound hydroethanolic extraction, and natural deep eutectic solvents–ultrasound extraction methods on STF231 to obtain extracts with antioxidant activity. The extraction profile of total polyphenols (TPCs) was measured using the Folin–Ciocalteu test and the antioxidant capacity of the extracts was tested with FRAP and DPPH assays. HPLC-UV was employed to quantify the phenolic and iridoid markers in the extracts. Additionally, the sustainability profile of the process was assessed using the green analytical procedure index (GAPI), AGREEprep, and analytical GREEnness metric approach (AGREE) frameworks. Our findings indicate that a choline chloride and lactic acid mixture at a 1:5 ratio, under optimal extraction conditions, resulted in extracts with higher TPC and similar antioxidant activity compared with conventional hydroethanolic extracts. The innovative aspect of this study lies in the potential application of sustainable upcycling protocols to a previously unexamined matrix, resulting in extracts with potential health applications.

Titanium dioxide nanoparticles (TiO₂ NPs) are well suited for cosmetics and polymer films because they efficiently absorb UV light while remaining transparent to visible light. Their widespread use requires strategies for managing potential human and environmental risks. Implementing the Safe and Sustainable by Design (SSbD) methodology to advanced chemicals and materials is a major global challenge and a concept that is included in several EU research projects. This study employed a SSbD strategy by functionalizing the surface of TiO₂ nanoparticles with a lipopeptide-based biosurfactant (Sodium Surfactin, SS). A colloidal heterocoagulation approach was used to produce SS-modified TiO₂ nanoparticles. Different design options (TiO₂ source, order of addition, TiO₂/SS weight ratio) were investigated, and the properties were compared by measuring the UV filtering capability, photoreactivity, dustiness index, biological and ecotoxicological endpoints. This allowed us to estimate the safety and sustainability profile in agreement with the steps suggested by the JRC SSbD framework. The lipopeptide-based coating was essential for managing UV light-induced photoactivity and significantly lowering both in vitro cytotoxicity and ecotoxicity while simultaneously enhancing photostability when applied in cosmetic formulations. These results demonstrate that a colloidal process, which can be easily scaled up for industrial purposes, is a promising and exploitable SSbD strategy for the design and implementation of TiO₂ NPs based UV filters.

The involvement of oxidative stress in the aetiology of various multifactorial diseases is well known, just as the design of multifunctional compounds is recognized as an innovative strategy to control complex-spectrum diseases. The purpose of this work was to synthesize a small library of six benzothiazole derivatives with hydrazonic spacers and to evaluate their multifunctional efficacy in terms of antioxidant, UV-filtering, antiproliferative, and anti-inflammatory activities. From the SAR study it emerged that the hydrazone linker, when coupled with a hydroxyl group in position 4 and another hydroxyl or methoxyl in position 3, seems to direct the profile of the molecule towards multifunctionality. The antitumor activity against melanoma cells seems to be related to the inhibition of tyrosinase (BZTidr10-12). All the compounds of the series have shown to be direct inhibitors of 5-lipoxygenase (5-LO). In particular, compound BZTidr12, with an IC₅₀ of 0.03 µM, proved to be the most potent inhibitor of the series against isolated 5-LO activity in a cell-free assay.

In a recent study, we obtained two novel cortisone-derived molecules: 1,9β,17,21- tetrahydroxy-4-methyl-19-nor-9β-pregna-1,3,5(10)-trien-11,20-dione(SCA)and 1,9β,17,20β,21-pentahydroxy-4-methyl-19-nor-9β-pregna-1,3,5(10)-trien-11-one(SCB). These compounds showed a dual activity combining potent anti-inflammatory and antioxidant properties, suggesting their potential as therapeutic agents for conditions characterized by inflammation and oxidative stress, such as severe ocular disorders. In this study, in vitro experiments using human ARPE-19 and mouse 661 W cell lines, which model the retinal pigment epithelium and retinal photoreceptors respectively, revealed that pretreatment with SCA and SCB under oxidative stress with H₂O₂ preserved cell viability, reduced intracellular ROS levels, maintained tight junction integrity and Trans Epithelial Electrical Resistance (TEER). Moreover, both compounds enhanced mitochondrial respiration, thereby improving cellular bioenergetics. These results indicate that SCA and SCB could provide an effective alternative to traditional corticosteroids in treating complications in which oxidative stress and inflammation are combined, including diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). Preclinical studies on animal models and trials on human ocular diseases are necessary to validate these findings in vivo and explore their therapeutic potential.